Law Firm Seeks Nektar Investors to Lead Securities Suit Over REZOLVE‑AA Trial Claims

Overview

• Glancy Prongay Wolke & Rotter LLP invited Nektar shareholders with losses to seek lead‑plaintiff status by May 5, 2026.
• The complaint alleges that between February 26 and December 15, 2025, enrollment in the REZOLVE‑AA trial did not follow required instructions and protocol standards.
• Plaintiffs say those enrollment issues likely hurt the study’s results, which they argue made public statements about the trial’s strength misleading.
• The suit claims Nektar’s positive comments about its business, operations, and prospects lacked a reasonable basis during the stated period.
• The notice provides contact details for interested investors and states the release may be considered attorney advertising.